FDA Issues Warning on ‘Actos’ and Bladder Cancer, Fails to Join France and Germany in Drug Recall

On June 15, 2011, the U.S. Food and Drug Administration (FDA) released a ‘Drug Safety Communication,’ informing the public that use of the diabetes medication Actos (pioglitazone) for more than…

More in Health >